AMHR2 and ovarian cancer: Our data derived from both transplantable and autochthonous ovarian tumor models show that vaccination against AMHR2-CD, a defined fragment of an ovarian differentiation protein expressed in the vast majority of human EOCs, provides effective therapy and prophylaxis against ovarian cancer.